139 related articles for article (PubMed ID: 29655674)
1. Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.
Cron MA; Maillard S; Delisle F; Samson N; Truffault F; Foti M; Fadel E; Guihaire J; Berrih-Aknin S; Le Panse R
Autoimmun Rev; 2018 Jun; 17(6):588-600. PubMed ID: 29655674
[TBL] [Abstract][Full Text] [Related]
2. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
Cron MA; Guillochon É; Kusner L; Le Panse R
Front Immunol; 2020; 11():1074. PubMed ID: 32587589
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.
Sengupta M; Wang BD; Lee NH; Marx A; Kusner LL; Kaminski HJ
PLoS One; 2018; 13(10):e0205464. PubMed ID: 30308012
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774
[TBL] [Abstract][Full Text] [Related]
5. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.
Cron MA; Payet CA; Fayet OM; Maillard S; Truffault F; Fadel E; Guihaire J; Berrih-Aknin S; Liston A; Le Panse R
J Neuroinflammation; 2020 Oct; 17(1):294. PubMed ID: 33032631
[TBL] [Abstract][Full Text] [Related]
7. Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis.
Cron MA; Maillard S; Truffault F; Gualeni AV; Gloghini A; Fadel E; Guihaire J; Behin A; Berrih-Aknin S; Le Panse R
Front Immunol; 2019; 10():539. PubMed ID: 30984166
[TBL] [Abstract][Full Text] [Related]
8. miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.
Bortone F; Scandiffio L; Marcuzzo S; Bonanno S; Frangiamore R; Motta T; Antozzi C; Mantegazza R; Cavalcante P; Bernasconi P
Front Immunol; 2020; 11():142. PubMed ID: 32210951
[TBL] [Abstract][Full Text] [Related]
9. [Over-expression of CCL21 up-regulates the antigen presentation-related genes of CK8/18 positive thymic epithelial cells in patients with myasthenia gravis].
Zhang Y; Zhao J; Zhu Z; Yin T; Xuan X; Liu P; Li Q; DU Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):957-60. PubMed ID: 26146068
[TBL] [Abstract][Full Text] [Related]
10. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia.
Berrih-Aknin S; Ruhlmann N; Bismuth J; Cizeron-Clairac G; Zelman E; Shachar I; Dartevelle P; de Rosbo NK; Le Panse R
Ann Neurol; 2009 Oct; 66(4):521-31. PubMed ID: 19847900
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis.
Thomas S; Fayet OM; Truffault F; Fadel E; Provost B; Hamza A; Berrih-Aknin S; Bonnefont JP; Le Panse R
J Neuroinflammation; 2021 Nov; 18(1):270. PubMed ID: 34789272
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
13. miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells.
Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
J Neuroimmunol; 2018 Jul; 320():125-132. PubMed ID: 29661539
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a-5p enhances cell proliferation in medullary thymic epithelial cells via regulating TGF-β signaling.
Guo D; Ye Y; Qi J; Zhang L; Xu L; Tan X; Yu X; Liu Q; Liu J; Zhang Y; Ma Y; Li Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):840-9. PubMed ID: 27411504
[TBL] [Abstract][Full Text] [Related]
15. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N
J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
[TBL] [Abstract][Full Text] [Related]
17. Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia.
Le Panse R; Cizeron-Clairac G; Bismuth J; Berrih-Aknin S
J Immunol; 2006 Dec; 177(11):7868-79. PubMed ID: 17114458
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review.
Saghazadeh A; Rezaei N
Int Immunopharmacol; 2022 Nov; 112():109205. PubMed ID: 36087508
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as potential biomarkers in myasthenia gravis patients.
Punga AR; Punga T
Ann N Y Acad Sci; 2018 Jan; 1412(1):33-40. PubMed ID: 29125182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
